The Australian Government is committed to offering every person in Australia access to safe and effective COVID-19 vaccines at no cost. From March 2021, 16 new MBS items will be available to enable GPs and suitably qualified health professionals to assess patient’s for their suitability to receive a COVID-19 vaccine. The MBS COVID-19 vaccine suitability assessment service is free to Medicare eligible patients and the MBS items must be bulk billed.
The MBS items are part of the Australian Government’s second phase of the COVID-19 vaccination program (known as phase 1B). Under this phase, the Government will work with accredited general practices, General Practitioner-led Respiratory Clinics and Aboriginal Community Controlled Health Services to vaccinate certain cohorts of persons aged 18 years of age or older. Accredited general practices will be supplied the AstraZeneca COVID-19 vaccine to commence vaccinating priority population groups, including persons 70 years of age or older, other health care workers, Aboriginal and Torres Strait Islanders 55 years or older, persons with an underlying medical condition, and critical and high risk workers.
General practice will also be involved in latter phases of the vaccination program which aims to vaccinate all Medicare-eligible persons aged 18 years of age and older. The majority of patients are expected to receive the vaccine twice.
MBS COVID-19 Vaccine Suitability Assessment Service Factsheet PDF (1008 KB)
Further news and information about the development, approval process and plans for COVID-19 vaccines can be found at https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines
Please note that the information provided is a general guide only and subject to revision. It is ultimately the responsibility of treating practitioners to use their professional judgment to determine the most clinically appropriate services to provide, and then to ensure that any services billed to Medicare fully meet the eligibility requirements outlined in the legislation.